Products

What will AGI do for Bismuth subcitrate?

This classification denotes a cytoprotective agent and anti-ulcer agent with the molecular formula 2C6H5O7.Bi.3K, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HS813P8QPX, chemically known as 1,2,3-propanetricarboxylic acid, 2-hydroxy-, bismuth(3+) potassium salt (2:1:3) but generally known as bismuth subcitrate, which bears US NIH Compound Identifier 6335486. European Medicines Agency schedules Bismuth subcitrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13089MIG. World Health Organization schedules bismuth subcitrate in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, BISMUTH SUBCITRATE remains the US FDA Preferred Term for this commodity. Bismuth subcitrate bears US NLM identifiers UMLS ID C0106556 and NCI Concept Code C1351. SMILES: C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Bi+3].

How AGI delivers it

Four ways AGI delivers for Bismuth subcitrate

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Bismuth subcitrate, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Bismuth subcitrate, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Bismuth subcitrate connects

measured by

  • Bismuth Assaymodel
  • Citrate Contentmodel
  • Heavy Metal Contentmodel
  • Loss On Dryingmodel
  • Particle Size Distributionmodel